FY2025 · ended Dec 31, 2025 · Revenue $25.12B, +11.2% YoY · Filed Feb 11, 2026
Stryker Corp (SYK) files with the SEC under industry code 3841, Surgical & Medical Instruments & Apparatus. In fiscal 2025, which ended Dec 31, 2025, it reported revenue of $25.1 billion and net income of $3.2 billion. Free cash flow was $4.3 billion. As of Sep 30, 2026 it held $3.3 billion in cash and investments and $15.7 billion in total debt.
Revenue (TTM)
$26.30B
+7.9% vs year-ago TTM
Net income (TTM)
$3.62B
+23.1% vs year-ago TTM
Operating cash flow (TTM)
$5.45B
+12.7% vs year-ago TTM
Free cash flow (TTM)
$4.57B
+12.3% vs year-ago TTM
EPS (TTM)
$9.39
+23.2% vs year-ago TTM
Dividend per share
$1.56
Shares outstanding
382.69M
+0.3% vs prior year
Net cash
$-12.41B
as of Sep 30, 2026
Operating margin
20.7%
FY 2026
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- SYK (NYSE)
- Fiscal year ends
- December 31
- Incorporated in
- MI
- Headquarters
- Portage, MI
- SEC filer status
- Large accelerated filer
- SEC CIK
- 310764
Other Surgical & Medical Instruments & Apparatus companies
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
- West Pharmaceutical Services Inc WST
All 151 Surgical & Medical Instruments & Apparatus companies
Key figures
Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.
| Line | FY 2025 Dec 31, 2025 |
FY 2024 Dec 31, 2024 |
FY 2023 Dec 31, 2023 |
FY 2022 Dec 31, 2022 |
FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| Revenue | $25.1B | $22.6B | $20.5B | $18.4B | $17.1B |
| Operating income | $4.9B | $3.7B | $3.9B | $2.8B | $2.6B |
| Net income | $3.2B | $3.0B | $3.2B | $2.4B | $2.0B |
| Diluted EPS | $8.40 | $7.76 | $8.25 | $6.17 | $5.21 |
| Operating cash flow | $5.0B | $4.2B | $3.7B | $2.6B | $3.3B |
| Free cash flow | $4.3B | $3.5B | $3.1B | $2.0B | $2.7B |
| Total assets | $47.8B | $43.0B | $39.9B | $36.9B | $34.6B |
| Total liabilities | $25.4B | $22.3B | $21.3B | $20.3B | $19.8B |
| Stockholders' equity | $22.4B | $20.6B | $18.6B | $16.6B | $14.9B |
| Cash and investments | $4.1B | $3.7B | $3.1B | $1.9B | $3.0B |
| Total debt | $16.4B | $14.1B | $13.5B | $13.5B | $12.9B |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Oct 30, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Results of operations
|
Oct 29, 2026 | Oct 29, 2026 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Oct 6, 2026 | Oct 6, 2026 |
| 10-Q | Quarterly report | Jul 31, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Jul 30, 2026 | Jul 30, 2026 |
| 8-K |
Current report
Other events
|
Jun 26, 2026 | Jun 26, 2026 |
All 1001 Stryker Corp SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.